plitudes correlates with postoperative motor weakness. Larger-amplitude changes have been found to predict a more
Neurogenic MEPs
Neurogenic MEPs (NMEPS) are responses recorded
MOTOR EVOKED POTENT'IALS
from the peripheral nerve following stimulation of the spinal MEPs are elicited by initiating a depolarizing action pocord (see Fig. 1 ) Although NMEPs are relatively resistant to tential in the pyramidal cell axons via a current applied directly anesthetic depression, the spinal stimulation used to elicit the or transcranially to the cerebral cortex or spinal cord. Transresponses activates both orthodromic motor and antidromic cranial stimulation can be achieved with high-voltage, shortsensory pathways, making NMEPS nonspecific for motor duration electrical stimulators, or magnetic field induction at fun~tion.~ Collision studies in human subjects suggest that the the level of the scalp. Either stimulus technique can be applied responses may be purely sensory, with motor responses due to multiple areas of the proximal motor structures to generate only to sensory and motor connections at the spinal level." responses, including the motor cortex, the pyramidal decussaRecent reports of unchanged intraoperative NMEPs and sotion at the brain stem, and the proximal spinal tracts. matosensory evoked potentials (SSEPs) in two patients with MEPs can be recorded from multiple points along the postoperative motor deficits confirm a mainly sensory contrimotor structures as the action potential initiated in the motor bution."
I Neurosura Anesthesiol Volume 16, Number Thorac. Cordiovasc. Surg. 1998; 10:19-24.) summation of potentials from the depolarization of multiple muscle fibers. Muscle activation requires the synaptic transmission of corticospinal impulses to the alpha motor neuron at the level of the ventral gray matter. The amplitude of the response is proportional to the number of motor fibers contributing to the potential, which in turn is determined by the number of alpha motor neurons activated. Transcranially stimulated myogenic responses have the advantage of monitoring the entire motor system, including the ischemia-sensitive ventral gray matter. Muscle responses also appear to be more sensitive to spinal ischemia than epidural responses.12
The synaptic transmission required to stimulate the alpha motor neuron to produce CMAP responses causes extreme sensitivity to the inhibitory effects of many anes.thetic agents. Stimulus techniques using multiple stimuli in close succession (multi-pulse stimulation) increase response amplitudes by creating temporal summation of several excitatory postsynaptic potentials at the anterior horn cell, thereby increasing the likelihood of reaching firing threshold in the motor neuron.13-l5 Myogenic response amplitudes obtained under general anesthesia show a large amount of interpatient and intrapatient trial-to-trial amplitude variability, confounding the interpretation of CMAP amplitude changes. Because of the high rate of amplitude variability, specific warning criteria for amplitude and latency changes in myogenic MEPs have not been well established. Some authors have used only the presence or absence of myogenic potentials as an indicator of injury.16 Complete waveform loss has better specificity for postoperative injury than amplitude or latency changes.17 This paper will focus mainly on anesthetic and physiologic induced changes in intraoperative myogenic MEPs.
PHARMACOLOCIC INFLUENCES Volatile Anesthetics
Halogenated inhalational agents cause significant dosedependent depression of myogenic response amplitudes and can increase monitoring failure rates at clinically relevant doses (Table 1) . Volatile agents inhibit the pyramidal activation of spinal motor neurons at the level of the ventral h~r n . '~~'~ Spinal volleys created by single-pulse transcranial stimuli are inadequate to overcome the suppressive effect of even a low-dose inhalational agent (0.25-0.5 MAC).'"-^^ Volatile suppression can be partially overcome by using higher-intensity stimuli and multi-pulse stimulation. Stimulus trains of 3 to 5 pulses improve CMAP amplitudes (mean amplitudes 172 uV) and monitoring success under isoflurane concentrations up to 0.5 MAC (Fig. 2) ." However, a s end-tidal concentrations increase beyond 0.5 MAC, a percentage of subjects lose myogenic responses despite the use of multi-pulse stimuli. Concentrations of 0.75 and 1 MAC isoflurane reportedly produce adequate CMAP responses in only 61% and 8% of patients, respectively, after multi-pulse transcranial electrical tim mu la ti on.^^'^^ Dual-pulse electrical stimuli generate CMAP responses in only 55% of patients at 0.5 MAC sevoflurane and 10% at 0.75
Other volatile agents show similar depressive Direct stimulation of the motor cortex following craniotomy improves myogenic MEP acquisition over transcranial stimulation in the presence of volatile anesthetics. CMAP responses can be seen at 0.75 to 1.5 MAC isoflurane and sevoflurane following direct motor cortical s t i m~l a t i o n .~~ Volatile agents have much less effect on transcranially elicited spinal D-wave potentials than on myogenic responses. While the transsynaptically generated I-waves show 50% depression at 1 MAC of volatile agent, little change occurs in the D-wave amplitude.3s34 _
Nitrous Oxide
Nitrous oxide (N20) appears to be less suppressive than other inhaled agents and can be used in moderate doses to supplement other agents during myogenic MEP monitoring. Multi-pulse stimulus techniques have been shown to partially reverse the N20-induced amplitude depression and response variability previously reported during single-pulse stimulation.35-37 The addition of up to 50% N20 to less suppressive anesthetic regimens such as opioid, ketamine, or low-dose propofol infusions (20-50 pgkglmin) does not cause significant myogenic response amplitude depression when multi-pulse stimuli are applied t r a n s~r a n i a l l y .~~~~~ Reversal of amplitude suppression caused by higher doses of N 2 0 (60-70%) is less reliable. A 50% to 70% reduction in CMAP amplitudes occurs with addition of 60% N 2 0 to an opioid and low-dose propofol (0.5-1 pg/mL) anesthetic despite a 6-pulse stimulus application. However, adequate (median 450 pV) and reproducible responses were obtained despite the moderate reduction in response size.39 Recent animal data suggest that the suppressive effects of other anesthetic agents may have a synergistic effect on N20-induced amplitude depression. The authors found that the CMAP amplitude reduction caused by 30% to 70% N 2 0 could be fully reversed by 5-pulse train stimuli when combined with agents known to have minimal effects on CMAP response amplitudes, such as ketaminelopioid infusions. However, N,O-induced suppression could not be reversed even with multi-pulse stimulation when combined with propofol at serum concentrations of 1.6 yg/m~.40 + Narcotic infusion.
.£Narcotic bolus. tN2O. §Midazolam 0.1 mgkglhr. #Ketarnine.
TPropofol40-50 mcgkglmin (1 pg/mL). 'Median size of CMAP amplitude after addition of drug. "% change in CMAP amplitude after addition of drug. "'N20 added to patients with four different TIVA regimens including alfentanil-etomidate, alfentanil-propofol, propofol-ketamine, midazolam-ketamine. ivSuccess of bilateral myogenic recording, unilateral recordng obtained in 61%. 'Approximate infusion rate to produce reported serum propofol concentration of 0.7-1 pg/mL. "~~~r o x i m a t e infusion rate to produce reported propofol serum concentrations of 1.4-2 pg/mL. " "~~~r o x i r n a t e infusion rate to produce reported propofol serum concentration of 3 pg/mL. ""'~e~orted serum propofol concentration of 5 pg/mL. '"study group included patients with preoperative motor dysfunction. "Infusion rate to induce loss of consciousness in 50% of patients. "'Numbers are approximate/extrapolated from box plot data.
Methohexital infusion maintains better monitoring conditions than thiopental, although some dose-dependent depression of CMAP does occur. Single-pulse, myogenic responses were lost in 60% to 80% of patients after infusion of subanesthetic doses of thiopental compared with 43% of patients anesthetized with induction doses of meth~hexital.~~ Using singletrain stimulation, Watt et a14' reported adequate tcM MEP production in seven of seven patients receiving methohexital (1 00 m c g / k g / m i n ) / a lentanil, ketamine (14-20 mcgkglmin), and iow-dose N,O (25%). The same authors later noted similar recording'success and faster emergence times with the omission of ketamine and the substitution of remifentanil for a l f e n t a~~i l .~~ Under singlepulse stimulation, anesthetic maintenance with methohexital provided better monitoring conditions than propofol infusion and comparable conditions to etomidate infusion.43 Use of multi-pulse stimuli in patients under methohexital anesthesia has not been reported.
Propofol
Despite its depressive effect on the motor system, the rapid metabolism and titratability of propofol have made it a popular anesthetic for use during evoked potential monitoring in cases requiring early postoperative emergence for neurologic examination. Thus, much energy has been spent on developing techniques that allow myogenic MEP monitoring under propofol infusion. Propofol suppresses activation of the alpha motor neuron at the level of the spinal gray matter.47 As with other agents, multi-pulse stimulation techniques can improve response amplitudes and monitoring success under propofol a n e~t h e s i a .~~
The dose-response curve of propofol CMAP suppression is difficult to ascertain due to variations in agent combination and muscle relaxation used by various authors. There does appear to be a limit to serum propofol levels above which myogenic MEP monitoring is compromised despite multi-pulse stimulus techniques. When serum propofol levels are maintained at or below 1 pglmL (20-25 pgkglmin) and supplemented by opioid/50% N,O, transcranial electric stimulation applied in 2 to 6 pulses produced CMAP responses in 100% of patients (median amplitudes 600-900 pV).38.39248 Serum propofol concentrations between 1 to 2 pg/mL (25-50 pgkglmin) caused a 30% to 60% reduction in CMAP amplitude despite multi-stimulus techniques, although response acquisition and reproducibility were well maintained.48 Above 3 pg/mL (75-100 pg/kg/min), greater variability in response depression has been reported, ranging from 33% to 83%.27,49 Response acquisition was adequate in only 60% to 88% of patients above this serum c o n c e n t r a t i~n . *~'~~~ Scheufler and zentnerS1 recently used transcranial magnetic stimulation to more clearly demonstrate the effects of propofol used as a single agent. At plasma propofol levels of 3 mcg/mL (75-100 pgkglmin), increasing stimuli rates from 2 to 4 pulses more than doubled CMAP amplitudes, generating mean waveforms of 5 17 pV. At higher serum propofol levels (25 p g / d [>lo0 pg/kg/min]), a greater amplitude depression was seen despite increasing impulse numbers, although CMAP responses did remain recordable with mean amplitudes of 264 p~. 5 '
Etomidate
Etomidate produces minimal suppression of myogenic transcranial MEPS when compared with barbiturates or propofol. Injection of an induction dose of etomidate (0.3 mgkg) does cause CMAP amplitude depression to 35% of baseline without changes in
The depressive effect, however, is short-lived, lasting only 2 to 5 minutes following bolus administration. Use of an etomidate infusion as a maintenance anesthetic provides excellent conditions for intraoperative FIGURE 2. Augmentation of myogenic motor evoked response amplitudes using multi-pulse transcranial stimuli in the presence of increasing doses of isoflurane. (Reprinted with permission: Ubags LH, Kalkman CJ, Been HD: Neurosurgery 1998; 43:90-94.) monitoring of myogenic MEPS. Several authors have reported good success in obtaining potentials with continuous infusions of etomidate in the range of 10 to 30 pgkg/rnin.53,54 Spinal potentials can be recorded following magnetoelectric stimulation bf the motor cortex even after etomidate-induced EEG suppression.55 The favorable effects of etomidate are thought to arise from its unique actions on the motor system at the spinal and supraspinal levels.56 Etomidate disinhibits subcortical structures, including the extrapyramidal system, the brain stem, and the spinal cord, resulting in increased excitability of the motor system.56v57 Although depression of the adrenocortical axis is a known complication of etomidate infusion, the possibility of postoperative adrenocortical suppression must be weighed against the benefits of minimal MEP depression offered by e t~m i d a t e .~~
Ketamine
Ketarnine used as an inhsion or a low-dose bolus has minimal effects on myogenic MEP responses. Both continuous infusions of ketamine (1-4 mgkgh) and intermittent boluses of ketamine (up to 0.5 mg/kg) used to supplement nitrous1narcotic anesthesia have been demonstrated to be compatible with intraoperative monitoring of motor potent i a l~.~~~~~~~~*~~ Higher doses of 4 to 8 mgtkg have been shown to cause a moderate depression of CMAP amplitudes (4540% of baseline) in animal models.61
Unfortunately, ketamine has a high incidence of psychedelic side effects, such as emergence delirium, hallucinations, and unpleasant dreaming. Kawaguchi et a14' reported psychedelic effects in 41% of patients receiving ketamine/narcotic infusions and inhaledN,O. Again, the risk ofthe potential side j Neurosurg Anesthesiol Volume 16, Number 1, 2004 Effects of Anesthetic Agents and Physiologic Changes on MEPs effects should be weighed against the risk of motor injury related to the planned procedure and the monitoring needs of the patient. Patients with preoperative motor weakness require less suppressive anesthetic agents like ketamine to obtain MEP potentials under anesthesia. The addition of low-dose propofol (15-50 pgikglrnin) to a ketamine infusion significantly reduced the incidence ofpsychotropic side effects to 14% of pat i e n t~.~~ However, propofol infusion doses higher than 30 pgkglmin will also decrease monitoring success, even in the presence of a 5-pulse stimulus technique.
Opioids
Opioids are commonly used to supplement anesthetic agents during motor monitoring and have only minimal effects on myogenic potentials when used as a low-dose, continuous infusion. Although opioids are known to cause suppression of cortical excitation, they appear to have little effect on transmission at the dorsal Fentanyl used alone in sedative doses (3 mcgkg) produces no significant change in the latency or amplitude of human CMAPs evoked by transcranial electric or magnetic ~timulation.~~ Larger doses of fentanyl(8 mcgkg) increased variability in the latency and amplitudes of singlepulse elicited CMAP in healthy volunteer^.^^ Despite this variability, potentials were reliably obtained in all patients.
In the presence of general anesthetics, bolus doses of fentanyl and morphine have been noted to cause prolonged CMAP amplitude depression.26 Animal data suggest that fentanyl, sufentanil, and alfentanil are about equal in their suppression of CMAP responses following bolus injection 6 ' As expectedwith its longer half-life, the depressive effects of fentanyl last significantly longer (15 minutes) than other agents. Dose-dependent CMAP depression (50% of baseline) does occur with opioid infusions adequate to produce surgical anesthesia with narcotics alone; however, responses are not abolished until serum levels reach twice surgical anesthesia c o n c e n t r a t i~n s .~~~~' Animal data suggest that remifentanil is less suppressive than other opioids. The serum level required to ablate myogenic responses is 20 times higher than that required for surgical anesthesia." Recent studies in humans have shown some dose-dependent reduction with remifentanil used as a single agent. At levels required for loss of responsiveness in 50% of patients (9 ng/mL [0.35 pg/kg/min]), CMAP amplitudes were reduced to 50% ofbaseline. However, potentials could still be followed with single-pulse stimulation even at plasma concentrations of 15 ng/mL (0.6 pg/kg/min).61
Benzodiazepines
Benzodiazepines can cause CMAP amplitude depression but are less depressive than propofol or thiopental. Diazepam (0.17 mgikg) has been found to have little effect on the MEP stimulus threshold, latency or amplitudes of myogenic tcM MEP when used as an anesthetic premedication.63 Bolus dosing ofmidazolam had previously been reported to decrease single-pulse elicited CMAP responses for up to 30 minutes following administration. However, more recent animal data demonstrated no significant effects of rnidazolam boluses when multi-pulse stimuli were Infbsions of 0.1 mgkg/h of midazolam produced no change in myogenic amplitudes or latency when used to supplement nondepressive anesthetics such as ketamine.64
Neuromuscular Blockade
Although neuromuscular blockade was initially avoided during monitoring of myogenic MEPs, adequate monitoring conditions can be obtained during partial neuromuscular blockade. Accurate assessment of neuromuscular blockade is necessary to maintain the balance between surgical relaxation requirements and adequate CMAP responses. Comparing electromyographic responses induced by an electrical stimulus applied to the peripheral nerve (M-response) before and after relaxation gives an accurate reflection of the degree of blockade at the neuromuscular junction. Using single-twitch Mresponses to maintain a single twitch height (Tl) of 20% to 50% of baseline facilitates surgery while allowing for reproducible CMAP responses.48~53~6s~66 Higher levels of neuromuscular blockade (5-10% of baseline) cause smaller amplitude potentials with greater trial-to-trial ~a r i a b i l i t y .~~,~~ Maintenance of a larger T1 height (44-55% of baseline) and a 6-pulse stimulus regimen has been shown to reduce response variation by 12% and to produce amplitudes similar in size to nonparalyzed condition^.^^ Partial neuromuscular blockade should be used with caution in patients with preoperative neurologic dysfunction. Lang et a1 found that patients with preoperative motor deficits demonstrated greater amplitude reductions after partial neuromuscular blockade than patients with normal preoperative motor function (mean 419 pV vs. 1,670 p~.~~
The level of neuromuscular blockade should be monitored in the same muscle group fiom which CMAP responses are obtained. M-responses are more accurate in assessing the effects of neuromuscular blockade on CMAP response than twitch monitoring by accelerometer at the thenar eminence.66 During increasing neuromuscular blockade, M-response arnplitudes in the target muscle group show a linear correlation with CMAP amplitudes, while the thenar twitch is more profoundly depressed.
M-responses can be used to differentiate between neurologic injury and increasing neuromuscular blockade. When monitoring combined transcranial CMAP and M-responses, reductions in both the CMAP and M-response potentials would suggest accumulating neuromuscular blockade due to muscle relaxants, whereas an unchanged M-response associated with a decreasing CMAP amplitude would indicate-motor tract injury or inhibition at a site more proximal than the neuromuscular junction. 
PHYSIOLOGIC INFLUENCES Temperature
Temperature-dependent alterations in nerve conduction velocity result in latency changes in MEPs. Several animal models have demonstrated a linear increase in latencies of the myogenic, neurogenic, and evoked spinal cord MEP potentials during hyp~thermia.~~-~l The stimulation threshold also increases with decreasing temperature, reflecting a cold-induced decrease in motor cortical excitability.67 Latency prolongation of spinal MEPs in rats suggests that spinal conduction velocity is decreased by 1.5 m/s per degree ent ti grade.^^ Hypothermia induced in animal models demonstrates a biphasic effect on the amplitude of CMAP responses. Amplitudes initially increase in size, peaking at 2g°C, and then progressively decrease until they are lost at 2 2 "~.~~ Despite these temperature effects on CMAP, time to detection of spinal cord ischemia was not different in hypothennic versus normothermic animals.68
Anecdotal evidence in humans suggest that reproducible myogenic MEP waveforms can be obtained during mild hypothermia to temperatures of 31 to 34"C, although latencies increase below 32°~.5,73,74 LOSS of spinal MEP potentials has been reported at 25°C in patients under circulatory arrest.74 Rewarming to normothermia reversed the effects of hypothermia and shortened MEP Regional spinal hyperthermia above 42°C slightly increases MEP latency.75 MEP waveform amplitudes decrease with body temperatures greater than 38°C. When spinal cord temperatures exceed 45"C, amplitude reduction becomes irreversible, suggesting that permanent neural injury occurs at these temperatures.75
Hypoxia
Little is known about the effects of hypoxia on human MEP responses. In animals, CMAP amplitudes remained unchanged until the inhaled oxygen concentration reached At this level of hypoxemia, 27% of animals lost MEP waveforms. The remaining animals showed a trend toward increased response latencies and depressed amplitudes, but the changes were not significant. MEP waveforms were lost in all animals only under extreme hypoxic conditions, with inhaled oxygen concentrations of 5.25%.76 This study suggested that CMAP responses are not significantly affected by hypoxia until the partial pressure of oxygen in the tissue reaches levels that have been associated with loss of ATP and cellular function. It is likely that critical reduction of neuronal tissue oxygenation by either decreased inspired concentrations of oxygen or by reduced oxygen delivery inhibits MEP potentials by disturbing oxidative metabolism and cell homeostasis.
Hypotension
Mild to moderate reductions in blood pressure do not induce MEP changes. Controlled hypotension in porcine models showed no significant decrease in spinal sciatic NMEP amplitudes until mean arterial pressures were decreased to below 50 r n r n~~.~l
The effect of hypotension on MEP in humans has been investigated with comparisons to normotensive controls. Reliable and reproducible spinal MEP potentials have been obtained in humans undergoing spinal surgery during deliberate hypotension to mean arterial pressures of 60 to 70 r n r n~~. ' .~~
Ischemia
Muscle responses generated by transcranial stimuli reflect cellular function at the level of the cortex, spinal cord, and muscle. Ischemia at any of these sites affects CMAP response amplitudes. In baboons, MEP changes induced by cortical ischemia were found to occur after reduction of cerebral blood flow to less than 16 mL/min/100 g.78 Ischemia of the lower limb muscles following aortic or femora1 cross-clamping will cause loss of myogenic responses within 30 minutes of occlusion.', Spinal cord ischemia induced by complete aortic occlusion will cause loss of myogenic responses within 2 minutes of occlusion. In contrast, spinal responses are reduced to only 40% of baseline after 25 minutes of spinal cord ischemia.',
Hyper-and Hypocapnia
Hypercapnia has been found to have depressive effects on cortical and anterior horn cell excitability, as well as peripheral neuromuscular transmis~ion.~~-~' However, clinically significant changes in MEP waveforms do not occur until extreme levels of CO, elevation are reached. In animals, changes in the latency or amplitude of the spinally elicited, sciatic MEP did not occur until PaCO, reached 70 m m~g .~' During transcranial stimulation, response amplitude and latency changes were seen only when PaC02 levels increased beyond 100 m m~~.
Hypocapnia may facilitate cellular transmission at the spinal leveI but has a slight inhibitory effect at the level of neuromuscular transmission.79782 These opposing effects result in minimal effect on evoked responses. Both animal and human models have demonstrated no alterations in myogenic MEP after hyperventilation to an end-tidal CO, between 13 and 30 m m~g .~~. '~
IMPLICATIONS FOR PERIOPERATIVE MONI-TORING
Multistimulus techniques have greatly improved the success of intraoperative MEP monitoring under general anesthesia. Providing an adequate atmosphere for motor monitoring requires maintenance of a stable anesthetic concentration and physiologic milieu. The anesthetic protocol used should take into consideration the overall requirements of the patient and surgical procedure. Total intravenous anesthetic techniques comprising infusions of opioid and minimally depressive agents such as ketamine, etomidate, and midazolam will provide the greatest success for intraoperative MEP monitor- Effects of Anesthetic Aqents and Phvsioloaic Chanaes on MEPs ing. However, the undesirable side effects and pharrnacokinetic properties of these agents can make them less than desirable in many patients. Use of higher pulse stimulus paradigms (3-6 pulses) can improve monitoring under more depressive agents with preferable pharmacologic profiles, such as propofol and isoflurane. However, these agents must be maintained at low doses for adequate monitoring conditions. Bolus dosing of amnestic agents and opioids can cause long-lasting (15-20 minutes) depression or obliteration of MEP responses and should be avoided. A microcomputercontrolled closed-loop infusion system is useful to provide a stable anesthetic concentration and muscle relaxation.
Physiologic causes of response depression, such as severe anemia, hypotension, and hypoxia, should be quickly ruled out when MEP changes occur. Continuous monitoring rather than monitoring only during risky maneuvers will help detect gradual changes in baseline potentials caused by anesthetic or physiologic alterations. When possible, motor groups above and below the surgical field should be monitored to help to dfferentiate between systemic and local causes of waveform depression.
Spinal Surgery
A number of anesthetic regimens have been demonstrated to be acceptable during MEP monitoring in spinal surgical procedures. Intravenous infusions of ketamine, etomidate, methohexital, midazolam, and low-dose propofol, combined with opioids and partial neuromuscular blockade, have been effective in neurologically normal patients undergoing spinal surgery.
Patients with preoperative motor pathway injury may have very small baseline potentials, which can be obliterated by the addition of moderately depressive anesthetic^.^,^^'^^'^^ Consideration should be given to the use of less depressive agents in these patients, such as etomidate or ketarnine added to an opioid infusion. Muscle relaxation has been suggested to cause greater MEP amplitude reduction in patients with preexisting motor deficits and is probably best avoided.53 Bite blocks should be used in unrelaxed patients, as masseter muscle contraction will occur with transcranial stimulation and can lead to tongue laceration. Remifentanil has only recently been introduced as part of the regimen for intraoperative monitoring, but it may provide an excellent adjunct in situations where muscle relaxation must be avoided and minimal dosing of arnnestic agents is required. The profound analgesic effect of remifentanil reduces anesthetic dose requirements.87 In addition, remifentanil has been shown to decrease movement in patients without neuromuscular blockade during highly stimulating procedures such as i n t u b a t i~n .~~'~~ Maintaining a depth of anesthesia that minimizes patient movement is particularly important when movement could lead to serious injury, such as when the patient's head has been positioned in a rigid pin fixation device during cervical surgery.
Craniotomy
Anesthetic goals differ for spinal and intracranial surgery. Reduction of cerebral metabolism and blood flow is often required during craniotomy to provide adequate brain relaxation for surgical resection. Prompt emergence and minimal postoperative sedation are also required to monitor for neurologic sequelae. Ketamine has traditionally been avoided during intracranial surgery due to concerns about increased cerebral blood flow intraoperatively and postoperative psychedelic side effects, whlch can confound the neurologic examination. Low-dose propofol (25-50 ygkg/min) and a shortacting narcotic can be used to satisfy the multiple requirements of craniotomy patients. However, the propofol dosing should be maintained at 50 pg/kg/min, and higher pulse stimuli regimens should be used for optimal monitoring. The short halflife and lack of accumulation make remifentanil an ideal opioid for avoiding excessive postoperative sedation after long procedures. Remifentanil is also useful for maintaining an adequate depth of anesthesia to avoid patient movement when the head position is fixed by rigid pins.
Direct stimulation of the cortex after craniotomy will overcome some volatile agent-induced MEP depression. Greater success in myogenic potential production has been demonstrated under combinations of volatile agents and N,O after direct cortical stimulation versus transcranial stimulat i~n .~~
The evidence suggests that physiologic manipulations ofie;n used as adjuncts to intraoperative management, such as controlled hypotension and mild hypothermia, generally do not decrease the reliability of motor m o r~i t o r i n~.~~~.~~.~~
Thoracic Aortic Reconstruction
MEP monitoring holds promise for reduction of postoperative paraplegia during thoracic aortic reconstruction (TAA). Myogenic MEP monitoring rapidly detects ventral horn ischemia and allows the surgeon to initiate strategies to improve spinal cord perfusion, such as intercostal artery reimplantation or increasing distal aortic perfusion pressures.6.12 Anesthetic requirements for surgical exposure, and the tendency for multiple comorbidity in this patient population, can make choosing an MEP-compatible anesthetic challenging during TAA repair. Agents that reduce myocardial contractility and cause hypotension are best avoided in patients undergoing TAA repair, as they often have widespread atherosclerotic disease. Various authors have reported success with the use of high-dose narcotic regimens supplemented by N,O, benzodiazepines, ketamine, or low-dose propofol for amnesia. 39.73,74.90 Partial muscle relaxation may be necessary for adequate exposure during the transthoracic approach and to facilitate single-lung ventilation. Stinson et a190 found that maintaining neuromuscular relaxation at less than 80% inhibition (based on the amplitude of a single-twitch elicited EMG response) was inadequate for surgical exposure, and greater than 90% ablated
